December 11, 2008 | Merck is creating a new generics division, clearly indicating the struggle Big Pharma is having over patents. The new division plans to file three new drugs with the FDA this year. Forbes.
For reprints and/or copyright permission, please contact Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.